Selumetinib (INN), sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis...
26 KB (2,192 words) - 08:10, 1 July 2024
Neurofibromatosis type I (section Selumetinib)
always be considered against its risks. Some NF tumours are inoperable. Selumetinib, is a drug produced by Astra Zeneca sold under the brand name Koselugo...
58 KB (6,749 words) - 13:25, 1 November 2024
(USAN) Selpak selprazine (INN) Selsun Selsun Blue seltraposin (INN) selumetinib (USAN) selurampanel (INN) selvacovatein (INN) semagacestat (USAN, INN)...
7 KB (370 words) - 22:19, 30 September 2024
treatment of advanced melanoma with a BRAF V600E or V600K mutation. Selumetinib, had a phase 2 clinical trial for non-small cell lung cancer (NSCLC)...
6 KB (719 words) - 23:12, 12 May 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
56 KB (5,566 words) - 13:30, 2 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
79 KB (7,258 words) - 10:40, 24 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
53 KB (4,975 words) - 03:43, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
91 KB (9,245 words) - 14:27, 17 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
16 KB (1,287 words) - 20:48, 11 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
42 KB (3,798 words) - 13:29, 20 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
31 KB (2,632 words) - 22:56, 26 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
42 KB (3,486 words) - 00:32, 30 September 2024
inhibitor - Approved 2022, collaboration with Mirati Therapeutics KOSELUGO (Selumetinib) - MEK1/2 inhibitor - Approved 2020, licensed by Astrazeneca VITRAKVI...
3 KB (184 words) - 15:23, 7 August 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
14 KB (1,368 words) - 21:56, 12 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
22 KB (2,320 words) - 13:06, 15 August 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (778 words) - 01:56, 27 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
79 KB (6,428 words) - 19:45, 22 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (836 words) - 03:56, 30 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
31 KB (2,777 words) - 08:32, 19 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
6 KB (352 words) - 17:16, 16 May 2024
to be highly toxic and cause diarrhea. Another investigated drug is selumetinib, a MAPK inhibitor. It improved survival, but did not correlate with any...
198 KB (21,235 words) - 06:47, 19 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
24 KB (1,917 words) - 17:27, 12 October 2024
inhibitors include cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found that acupoint-moxibustion...
24 KB (3,068 words) - 07:21, 7 June 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
8 KB (511 words) - 15:46, 7 September 2024
Momelotinib Pacritinib Ruxolitinib MAP2K (MEK) Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's (BTK)...
12 KB (821 words) - 02:57, 12 October 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
8 KB (967 words) - 18:35, 12 August 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
10 KB (799 words) - 13:28, 4 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
26 KB (2,484 words) - 07:20, 24 November 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
214 KB (17,080 words) - 15:51, 27 September 2024
Roxadustat Salbutamol/budesonide Savolitinib Saxagliptin Sebelipase alfa Selumetinib Sodium zirconium cyclosilicate Tamoxifen Ticagrelor Tixagevimab/cilgavimab...
18 KB (1,573 words) - 05:19, 15 October 2024